Cargando…
α7 Nicotinic Acetylcholine Receptor May Be a Pharmacological Target for Perioperative Neurocognitive Disorders
Background: The α7 nicotinic acetylcholine receptor (α7nAChR) is a promising therapeutic target in neurodegenerative diseases. This study examined the effects of surgery and anesthesia on α7nAChR expression in the central nervous system and determined the mechanisms by which α7nAChR mediates neuropr...
Autores principales: | Wei, Penghui, Lyu, Wenyuan, Xu, Lin, Feng, Hao, Zhou, Haipeng, Li, Jianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204176/ https://www.ncbi.nlm.nih.gov/pubmed/35721159 http://dx.doi.org/10.3389/fphar.2022.907713 |
Ejemplares similares
-
Methylpiperidinium Iodides as Novel Antagonists for α7 Nicotinic Acetylcholine Receptors
por: López, Jhon J., et al.
Publicado: (2018) -
COVID-19: a novel risk factor for perioperative neurocognitive disorders
por: Wei, Penghui, et al.
Publicado: (2021) -
Alkaloid ligands enable function of homomeric human α10 nicotinic acetylcholine receptors
por: Hone, Arik J., et al.
Publicado: (2022) -
Unravelling the allosteric binding mode of αD-VxXXB at nicotinic acetylcholine receptors
por: Ho, Thao NT, et al.
Publicado: (2023) -
Autophagy is Involved in Neuroprotective Effect of Alpha7 Nicotinic Acetylcholine Receptor on Ischemic Stroke
por: Xu, Zhe-Qi, et al.
Publicado: (2021)